By Jeff Overley ( December 2, 2013, 7:50 PM EST) -- Pfizer Inc. unit Meridian Medical Technologies Inc. botched several aspects of quality control surrounding production of nerve agent antidotes that have subsequently fallen into short supply, according to a U.S. Food and Drug Administration inspection report released Friday that echoed previous criticism. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.